Company Filing History:
Years Active: 2024-2025
Title: Mukund Ghavre: Innovator in Proliferative Disease Treatment
Introduction
Mukund Ghavre is a notable inventor based in Saint-Laurent, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of 2 patents to his name, Ghavre's work is recognized for its potential impact on healthcare.
Latest Patents
Ghavre's latest patents focus on Pyrido[3,2-d]pyrimidine compounds. These compounds are designed for use in treating proliferative diseases associated with RAF and RAS gene mutations. The patents detail compounds, compositions, and their applications in addressing these medical conditions. The compounds disclosed are of Formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R, R, R, X, X, X, and X are defined within the patent documentation.
Career Highlights
Mukund Ghavre is affiliated with the Université de Montréal, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to developing effective treatments for complex diseases.
Collaborations
Ghavre collaborates with esteemed colleagues, including Pierre Louis Beaulieu and Eric Beaulieu. These partnerships enhance the research and development of innovative solutions in healthcare.
Conclusion
Mukund Ghavre's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving treatment options for proliferative diseases. His work exemplifies the importance of innovation in addressing critical health challenges.